Literature DB >> 21486568

Control of nuclear receptor activities in metabolism by post-translational modifications.

Wahiba Berrabah1, Pierrette Aumercier, Philippe Lefebvre, Bart Staels.   

Abstract

Nuclear receptors (NRs) are molecular transducers of endocrine and dietary signals allowing tissues to adapt their transcriptional responses to endogenous or exogenous cues. These signals act in many cases as specific ligands, converting of NRs into transcriptionally active molecules. This on-off mechanism needs, however, to be finely tuned with respect to the tissue environment and adjusted to the organism needs. These subtle adjustments of NR transcriptional activity are brought about by post-translational modifications (PTMs), which can be, in the case of orphan NRs, the sole regulatory mechanism. The role of PTMs, with a more specific focus on phosphorylation, affecting the functions of NR controlling metabolic events is described in this review.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21486568     DOI: 10.1016/j.febslet.2011.03.066

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  Exploring the emerging complexity in transcriptional regulation of energy homeostasis.

Authors:  Adelheid Lempradl; J Andrew Pospisilik; Josef M Penninger
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

3.  The biological clock and the molecular basis of lysosomal storage diseases.

Authors:  Gianluigi Mazzoccoli; Tommaso Mazza; Manlio Vinciguerra; Stefano Castellana; Maurizio Scarpa
Journal:  JIMD Rep       Date:  2015-01-13

Review 4.  LXRα Phosphorylation in Cardiometabolic Disease: Insight From Mouse Models.

Authors:  Maud Voisin; Matthew C Gage; Natalia Becares; Elina Shrestha; Edward A Fisher; Ines Pineda-Torra; Michael J Garabedian
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

Review 5.  Signaling by nuclear receptors.

Authors:  Richard Sever; Christopher K Glass
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

6.  Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.

Authors:  Danielle Pasquel; Aneta Doricakova; Hao Li; Sandhya Kortagere; Matthew D Krasowski; Arunima Biswas; William G Walton; Matthew R Redinbo; Zdenek Dvorak; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2016-02-23

Review 7.  PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.

Authors:  Lu Han; Wen-Jun Shen; Stefanie Bittner; Fredric B Kraemer; Salman Azhar
Journal:  Future Cardiol       Date:  2017-06-05

8.  Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.

Authors:  Fleur Lien; Alexandre Berthier; Emmanuel Bouchaert; Céline Gheeraert; Jeremy Alexandre; Geoffrey Porez; Janne Prawitt; Hélène Dehondt; Maheul Ploton; Sophie Colin; Anthony Lucas; Alexandre Patrice; François Pattou; Hélène Diemer; Alain Van Dorsselaer; Christophe Rachez; Jelena Kamilic; Albert K Groen; Bart Staels; Philippe Lefebvre
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

Review 9.  Retinoic acid actions through mammalian nuclear receptors.

Authors:  Pengxiang Huang; Vikas Chandra; Fraydoon Rastinejad
Journal:  Chem Rev       Date:  2013-12-05       Impact factor: 60.622

10.  Nordihydroguaiaretic Acid, a Lignan from Larrea tridentata (Creosote Bush), Protects Against American Lifestyle-Induced Obesity Syndrome Diet-Induced Metabolic Dysfunction in Mice.

Authors:  Jackie K W Chan; Stefanie Bittner; Alex Bittner; Suman Atwal; Wen-Jun Shen; Mohammed Inayathullah; Jayakumar Rajada; Mark R Nicolls; Fredric B Kraemer; Salman Azhar
Journal:  J Pharmacol Exp Ther       Date:  2018-02-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.